Literature DB >> 10209678

Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice.

L B Adams1, M C Dinauer, D E Morgenstern, J L Krahenbuhl.   

Abstract

OBJECTIVE: To study the role of reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) in host response to Mycobacterium tuberculosis.
DESIGN: M. tuberculosis infection (i.v.) was compared in B6 control and two strains of knockout (KO) mice. X-CGD mice with a nonfunctional allele for the gp91phox subunit of the phagocyte oxidase cytochrome b are unable to produce ROI whereas iNOS KO mice lack a functional inducible nitric oxide synthase (iNOS) gene and fail to make RNI.
RESULTS: M. tuberculosis growth was markedly enhanced in the lungs of X-CGD mice compared to B6 mice, but was controlled in the spleen and liver. In iNOS KO mice, M. tuberculosis growth was exacerbated in the spleen, but was unremarkable in the lungs compared to B6 mice until later (Day 60) in the infection. In vitro, X-CGD alveolar and peritoneal macrophages (M phi) produced no ROI, but did produce RNI and inhibited growth of M. tuberculosis when activated with interferon gamma. iNOS KO M phi produced ROI, but failed to produce RNI and could not cope with M. tuberculosis in vitro when activated. The inhibition of M. tuberculosis growth observed in activated B6 and X-CGD M phi) was reversed in the presence of aminoguanidine.
CONCLUSION: These KO mouse strains demonstrate the relative potent effects of ROI and RNI in resistance to M. tuberculosis and should prove useful for the study of regulatory and compensatory mechanisms of immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10209678     DOI: 10.1016/s0962-8479(97)90004-6

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  69 in total

1.  Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis.

Authors:  T Akaki; H Tomioka; T Shimizu; S Dekio; K Sato
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.

Authors:  Jacinta Bustamante; Andres A Arias; Guillaume Vogt; Capucine Picard; Lizbeth Blancas Galicia; Carolina Prando; Audrey V Grant; Christophe C Marchal; Marjorie Hubeau; Ariane Chapgier; Ludovic de Beaucoudrey; Anne Puel; Jacqueline Feinberg; Ethan Valinetz; Lucile Jannière; Céline Besse; Anne Boland; Jean-Marie Brisseau; Stéphane Blanche; Olivier Lortholary; Claire Fieschi; Jean-François Emile; Stéphanie Boisson-Dupuis; Saleh Al-Muhsen; Bruce Woda; Peter E Newburger; Antonio Condino-Neto; Mary C Dinauer; Laurent Abel; Jean-Laurent Casanova
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

3.  Identification of some DNA damage-inducible genes of Mycobacterium tuberculosis: apparent lack of correlation with LexA binding.

Authors:  P C Brooks; F Movahedzadeh; E O Davis
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

4.  Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst.

Authors:  D L Piddington; F C Fang; T Laessig; A M Cooper; I M Orme; N A Buchmeier
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

6.  Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase.

Authors:  Carlos H C Serezani; David M Aronoff; Sonia Jancar; Peter Mancuso; Marc Peters-Golden
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

7.  The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates.

Authors:  R Colangeli; A Haq; V L Arcus; E Summers; R S Magliozzo; A McBride; A K Mitra; M Radjainia; A Khajo; W R Jacobs; P Salgame; D Alland
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  Reaction of Mycobacterium tuberculosis cytochrome P450 enzymes with nitric oxide.

Authors:  Hugues Ouellet; Jérôme Lang; Manon Couture; Paul R Ortiz de Montellano
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

9.  Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease.

Authors:  M Fujita; E Harada; T Matsumoto; Y Mizuta; S Ikegame; H Ouchi; I Inoshima; S Yoshida; K Watanabe; Y Nakanishi
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

10.  Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening.

Authors:  Katherine B Hisert; Meghan A Kirksey; James E Gomez; Alexandra O Sousa; Jeffery S Cox; William R Jacobs; Carl F Nathan; John D McKinney
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.